MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

09 Aug 2026 Evaluate
A fair growth of 20.10% in the revenue at Rs. 312.81 millions was reported in the June 2026 quarter as compared to Rs. 260.46 millions during year-ago period.A comparatively good net profit growth of 41.65% to Rs. 47.14 millions was reported for the quarter ended June 2026 compared to Rs. 33.28 millions of previous same quarter.Operating profit surged to 73.16 millions from the corresponding previous quarter of 53.98 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 312.81 260.46 20.10 312.81 260.46 20.10 1036.56 1009.74 2.66
Other Income 9.35 18.37 -49.10 9.35 18.37 -49.10 40.01 21.50 86.09
PBIDT 73.16 53.98 35.53 73.16 53.98 35.53 211.31 216.51 -2.40
Interest 0.21 0.16 31.25 0.21 0.16 31.25 1.27 0.82 54.88
PBDT 72.95 53.82 35.54 72.95 53.82 35.54 210.04 215.69 -2.62
Depreciation 9.64 9.04 6.64 9.64 9.04 6.64 37.03 36.47 1.54
PBT 63.31 44.78 41.38 63.31 44.78 41.38 173.01 179.22 -3.47
TAX 16.17 11.50 40.61 16.17 11.50 40.61 41.93 45.65 -8.15
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -3.36 0.40 -940.00
PAT 47.14 33.28 41.65 47.14 33.28 41.65 131.08 133.57 -1.86
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 23.39 20.72 12.85 23.39 20.72 12.85 20.39 21.44 -4.93
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..